Literature DB >> 30143971

Changes in immune cell frequencies in primary and secondary lymphatic organs of LEW.1AR1-iddm rats, a model of human type 1 diabetes compared to other MHC congenic LEW inbred strains.

Tanja Arndt1, Anne Jörns1, Dirk Wedekind2.   

Abstract

The LEW.1AR1-iddm rat is an animal model of human type 1 diabetes, which arose through a spontaneous mutation in the Dock8 gene within the MHC congenic background strain LEW.1AR1. This mutation not only mediates diabetes development but also leads to a variable T cell frequency in peripheral blood. In this study, the immune cell frequencies of primary and secondary lymphatic organs of LEW.1AR1-iddm rats were analysed at days 40 and 60 and compared to other MHC congenic LEW rat strains. In LEW.1AR1-iddm rats, the secondary lymphatic organs such as lymph nodes and spleen showed a reduced, around 15% in comparison to all other strains, but very variable T cell frequency, mirroring the fluctuating T cell content in blood. On the other hand, the frequency of B cells was increased by 10% in the lymph nodes and by 5% in the spleen. Thus, the decreasing number of T cells in blood could not be caused by an increase of T cells in secondary lymphatic organs. The frequency of single- or double-positive T cells in the thymus was unaffected. The T cell frequencies in the other analysed strains were more stable and mostly higher in all secondary lymphatic organs. Obviously, the Dock8 mutation leads to variabilities of T cell frequencies in blood as well as in secondary lymphatic organs. In conclusion, the Dock8 mutation was responsible for changed immune cell frequencies in different compartments and together with the RT1B/Du haplotype causing immune imbalances and development of autoimmune diabetes.

Entities:  

Keywords:  Congenic LEW strains; Dock8; Immune cells; LEW.1AR1-iddm rat; MHC II; Secondary lymphatic organs; Type 1 diabetes

Mesh:

Substances:

Year:  2018        PMID: 30143971     DOI: 10.1007/s12026-018-9015-6

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  32 in total

1.  DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses.

Authors:  Yosuke Harada; Yoshihiko Tanaka; Masao Terasawa; Markus Pieczyk; Katsuyoshi Habiro; Tomoya Katakai; Kyoko Hanawa-Suetsugu; Mutsuko Kukimoto-Niino; Tomoko Nishizaki; Mikako Shirouzu; Xuefeng Duan; Takehito Uruno; Akihiko Nishikimi; Fumiyuki Sanematsu; Shigeyuki Yokoyama; Jens V Stein; Tatsuo Kinashi; Yoshinori Fukui
Journal:  Blood       Date:  2012-03-28       Impact factor: 22.113

2.  Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes.

Authors:  Anne Jörns; Tanja Arndt; Andreas Meyer zu Vilsendorf; Jürgen Klempnauer; Dirk Wedekind; Hans-Jürgen Hedrich; Lorella Marselli; Piero Marchetti; Nagakatsu Harada; Yutaka Nakaya; Gen-Sheng Wang; Fraser W Scott; Conny Gysemans; Chantal Mathieu; Sigurd Lenzen
Journal:  Diabetologia       Date:  2013-12-06       Impact factor: 10.122

3.  Loss of T cell and B cell quiescence precedes the onset of microbial flora-dependent wasting disease and intestinal inflammation in Gimap5-deficient mice.

Authors:  Michael J Barnes; Halil Aksoylar; Philippe Krebs; Tristan Bourdeau; Carrie N Arnold; Yu Xia; Kevin Khovananth; Isaac Engel; Sosathya Sovath; Kristin Lampe; Eleana Laws; Amy Saunders; Geoffrey W Butcher; Mitchell Kronenberg; Kris Steinbrecher; David Hildeman; H Leighton Grimes; Bruce Beutler; Kasper Hoebe
Journal:  J Immunol       Date:  2010-02-26       Impact factor: 5.422

4.  Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency.

Authors:  Melissa C Mizesko; Pinaki P Banerjee; Linda Monaco-Shawver; Emily M Mace; William E Bernal; Julie Sawalle-Belohradsky; Bernd H Belohradsky; Valerie Heinz; Alexandra F Freeman; Kathleen E Sullivan; Steven M Holland; Troy R Torgerson; Waleed Al-Herz; Janet Chou; Imelda C Hanson; Michael H Albert; Raif S Geha; Ellen D Renner; Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-02-04       Impact factor: 10.793

5.  Lymphopenia and abnormal lymphocyte subsets in the "BB" rat: relationship to the diabetic syndrome.

Authors:  P Poussier; A F Nakhooda; J A Falk; C Lee; E B Marliss
Journal:  Endocrinology       Date:  1982-05       Impact factor: 4.736

6.  The BB diabetic rat. Profound T-cell lymphocytopenia.

Authors:  R Jackson; N Rassi; T Crump; B Haynes; G S Eisenbarth
Journal:  Diabetes       Date:  1981-10       Impact factor: 9.461

7.  Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene.

Authors:  Armand J MacMurray; Daniel H Moralejo; Anne E Kwitek; Elizabeth A Rutledge; Brian Van Yserloo; Paul Gohlke; Sara J Speros; Ben Snyder; Jonathan Schaefer; Sabine Bieg; Jianjie Jiang; Ruth A Ettinger; Jessica Fuller; Terri L Daniels; Anna Pettersson; Kimberly Orlebeke; Bruce Birren; Howard J Jacob; Eric S Lander; Ake Lernmark
Journal:  Genome Res       Date:  2002-07       Impact factor: 9.043

8.  Dedicator of cytokinesis 8-deficient patients have a breakdown in peripheral B-cell tolerance and defective regulatory T cells.

Authors:  Erin Janssen; Henner Morbach; Sumana Ullas; Jason M Bannock; Christopher Massad; Laurence Menard; Isil Barlan; Gerard Lefranc; Helen Su; Majed Dasouki; Waleed Al-Herz; Sevgi Keles; Talal Chatila; Raif S Geha; Eric Meffre
Journal:  J Allergy Clin Immunol       Date:  2014-09-11       Impact factor: 10.793

9.  Cblb is a major susceptibility gene for rat type 1 diabetes mellitus.

Authors:  Norihide Yokoi; Kajuro Komeda; He-Yao Wang; Hideki Yano; Kazuhiro Kitada; Yuka Saitoh; Yutaka Seino; Kazuki Yasuda; Tadao Serikawa; Susumu Seino
Journal:  Nat Genet       Date:  2002-07-15       Impact factor: 38.330

10.  Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production.

Authors:  Katrina L Randall; Teresa Lambe; Andy L Johnson; Andy Johnson; Bebhinn Treanor; Edyta Kucharska; Heather Domaschenz; Belinda Whittle; Lina E Tze; Anselm Enders; Tanya L Crockford; Tiphaine Bouriez-Jones; Duncan Alston; Jason G Cyster; Michael J Lenardo; Fabienne Mackay; Elissa K Deenick; Stuart G Tangye; Tyani D Chan; Tahra Camidge; Robert Brink; Carola G Vinuesa; Facundo D Batista; Richard J Cornall; Christopher C Goodnow
Journal:  Nat Immunol       Date:  2009-11-08       Impact factor: 25.606

View more
  1 in total

Review 1.  Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Strategies for In Vivo Administration: Part-II.

Authors:  Raquel Vieira; Selma B Souto; Elena Sánchez-López; Ana López Machado; Patricia Severino; Sajan Jose; Antonello Santini; Amelia M Silva; Ana Fortuna; Maria Luisa García; Eliana B Souto
Journal:  J Clin Med       Date:  2019-08-28       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.